Blood Test Validation for Phenylketonuria Monitoring
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This study tests a new fingerstick blood test (PheCheck™) designed to help monitor phenylketonuria (PKU), a rare condition affecting how the body processes a protein called phenylalanine. If you or your child has PKU and are already being monitored for it, this study may help improve how your care team tracks the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child must be at least 1 year old and able to have a small blood sample taken from a fingerstick
- You must have been diagnosed with phenylketonuria (PKU)—including classical PKU, mild PKU, variant PKU, or high phenylalanine levels
- You must already be regularly monitored for PKU by a healthcare provider
- You or your legal guardian must be able to read and understand study instructions
- You must sign an informed consent form (or have your guardian sign for you if you're a minor)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new slow-release protein substitute for people with PKU, to see if it is acceptable and well-tolerated. You would try the product for 7 days, replacing your usual substitute, to see how it fits into your routine.
This study looks at whether checking phenylalanine levels at home more often helps people with classic PKU keep their levels in a healthy range. It may help you manage your diet and treatment more effectively.
This study tests a new home blood test (Egoo Phe) for measuring phenylalanine levels in people with PKU, as well as in healthy adults. It aims to see if it is accurate and easy to use.
This study tests a new medicine called sepiapterin to see if it can help control blood phenylalanine levels in people with PKU. The trial aims to find a safe and effective dose for different age groups.
This study looks at whether following specific care guidelines for phenylketonuria (PKU) leads to better metabolic control (blood phenylalanine levels) and better patient well-being. You may be asked to complete questionnaires and follow the study plan while receiving the usual PKU treatment your clinic recommends.
This study is testing whether a new microtablet form of protein substitute is easy and acceptable for people with PKU to take. If you qualify, you'll take these tablets instead of your current protein substitute and share your experience with the research team.
Hear when a new Phenylketonuria (PKU) and Hyperphenylalaninemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.